Fresh2 - FRES Company Short-Term Debt

fresh2.co (FRES) - corporate logo

The market value dynamics of Fresh2 Group Limited (FRES) demonstrate the 0.00 metric, while the business faces disruptions in logistics chains and challenges in patent protection due to global conflicts. Fresh2 Group Limited (FRES) is striving to survive by pivoting toward bioinformatics, although its small scale leaves it vulnerable to industry behemoths. Growth relies on the digitalization of product distribution, which optimizes the interaction between farmers and the food service sector.

FRES (Fresh2 Group Limited) Company Short-Term Debts history from 02/21/2024 to 01/04/2025

Fresh2 Group Ltd - analytical breakdowns and key metrics (FRES)

- price and consensus price forecast:
Stock Price Fresh2|FRES - Analyst Consensus Forecast
- market capitalization data:
Market Value Fresh2 Group Limited|FRES - Business Value
- book capitalization data:
Book Value per Share Fresh2 Group|FRES - Book Capitalization|Market Value to Book Value Ratio fresh2.co|FRES - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Fresh2 Group Limited|FRES - Long-Term Liabilities to Capital|Short-Term Debt to Equity Fresh2|FRES - Company Total Debt Obligations|Debts to Book Capitalization Fresh2 Group Limited|FRES - Long-Term Debt Volume|Company Short-Term Debt Fresh2 Group
Analysis of all company metrics:fresh2.co FRES
Finished products of Fresh2

Short-term debt measures the total volume of credit obligations with a maturity of up to one year, allowing an investor to assess current liquidity and default risk. Analyzing financial liabilities with a term of up to 12 months is critically important for Fresh2 Group Limited, as a controlled level of borrowing ensures the company's stability during its transformation from the biotech sector into the B2B commerce sphere.

Competitor analysis for Fresh2 Group Limited

Agilent - Company Short-Term Debts|DGX: Company Short-Term Debts|Company Short-Term Debt Illumina Corp|Exact Sciences Inc. (EXAS) - Company Short-Term Indebtedness|RVTY (Revvity, Inc.) - Company Short-Term Debts|Company Short-Term Debts BIO|Company Short-Term Debt Anbio (NNNN)|Company Short-Term Debt Sotera Health Corp SHC|QDEL: Company Current Liabilities|OPKO Health Corp. - Short-Term Debt|Company Short-Term Debt CDNA (CareDx, Inc.)|MRVI - Short-Term Debt Volume|Fulgent Genetics - Company Short-Term Debts|LAB (Standard BioTools Inc) - Short-Term Debt Volume|CTKB: Company Short-Term Debt|Short-Term Debt Volume OraSure Corp|XGN - Company Short-Term Debts|Current Liabilities MDXH (mdxhealth.com)|Company Short-Term Debt Lucid Diagnostics|Company Short-Term Loans and Borrowings Prenetics Global Limited PRE|IMDX (Insight Molecular) - Company Short-Term Debts|TRIB: Short-Term Debt|ProPhase Labs, Inc. - Company Short-Term Debt|ainos.com (AIMD) - Short-Term Debt Volume|CODX - Company Short-Term Debts|Company Short-Term Loans and Borrowings HSCS|Company Short-Term Debt BMRA (Biomerica, Inc)|CDIO (cardiodiagnosticsinc.com) - Company Current Liabilities|Company Short-Term Loans and Borrowings VRAX (Virax Biolabs Group)|Company Short-Term Debts bluejaydx.com|AWH - Short-Term Indebtedness|Company Short-Term Debt AXDX (Accelerate Diagnostics Inc.)|Centogene NV (CNTG) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Enzo Biochem (ENZ)|Short-Term Debt GENE|Company Current Liabilities 23andme.com|Company Short-Term Debts Psychemedics Corporation (PMD)